GlucaPharm is developing GEP44, a novel, patented peptide (similar in function to Ozempic®, Wegovy®, Mounjaro®, but with reduced risk of adverse events) discovered by researchers at Syracuse University.Vancouver, British Columbia–(Newsfile Corp. – February 23, 2026)…

Vancouver, British Columbia–(Newsfile Corp. – December 12, 2025) – SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) (the "Company" or "SureNano") announces that it has granted 1,500,000 stock options to various directors, officers, and Consultants of…

Vancouver, British Columbia–(Newsfile Corp. – December 10, 2025) – SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) (the "Company" or "SureNano") is pleased to announce, as a follow-up to its news release dated November 5, 2025,…

Vancouver, British Columbia–(Newsfile Corp. – November 19, 2025) – SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) (the "Company" or "SureNano") is pleased to announce it has entered into a non-binding letter of intent (the "LOI")…

Vancouver, British Columbia–(Newsfile Corp. – November 5, 2025) – SURENANO SCIENCE LTD. (CSE: SURE) (OTCQB: SURNF) (the "Company" or "SureNano") announces its intention to complete a private placement for proceeds of up to $1,250,000 (the…